These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28024131)

  • 1. [Rating criteria for selection of an inhaler and instructing its use in patients with asthma and COPD].
    Ludwikowski R; Płusa T; Bijoś P
    Pol Merkur Lekarski; 2016 Dec; 41(246):279-282. PubMed ID: 28024131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care.
    Ding B; Small M; Scheffel G; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2018; 13():927-936. PubMed ID: 29588581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usage and usability of one dry powder inhaler compared to other inhalers at therapy start: an open, non-interventional observational study in Poland and Germany.
    Hantulik P; Wittig K; Henschel Y; Ochse J; Vahteristo M; Rytila P
    Pneumonol Alergol Pol; 2015; 83(5):365-77. PubMed ID: 26378998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler.
    Serra-Batlles J; Plaza V; Badiola C; Morejón E;
    J Aerosol Med; 2002; 15(1):59-64. PubMed ID: 12006146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey.
    Braido F; Baiardini I; Sumberesi M; Blasi F; Canonica GW
    Respir Res; 2013 Sep; 14(1):94. PubMed ID: 24053694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR).
    Lavorini F; Braido F; Baiardini I; Blasi F; Canonica GW;
    Pulm Pharmacol Ther; 2015 Oct; 34():25-30. PubMed ID: 26209820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaler devices in asthma and COPD patients - a prospective cross-sectional study on inhaler preferences and error rates.
    Schreiber J; Sonnenburg T; Luecke E
    BMC Pulm Med; 2020 Aug; 20(1):222. PubMed ID: 32819337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
    Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners.
    Molimard M; Colthorpe P
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):219-28. PubMed ID: 25265316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in inhaler devices for asthma and COPD.
    Capriotti T
    Medsurg Nurs; 2005 Jun; 14(3):185-94. PubMed ID: 16035636
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhaler mishandling is very common in patients with chronic airflow obstruction and long-term home nebuliser use.
    Melani AS; Canessa P; Coloretti I; DeAngelis G; DeTullio R; Del Donno M; Giacobbe R; Scarlato I; Serafini A; Barbato N; Vaghi A; Sestini P;
    Respir Med; 2012 May; 106(5):668-76. PubMed ID: 22277996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaler devices for asthma and COPD: choice and technique.
    Stevens N
    Prof Nurse; 2003 Jul; 18(11):641-5. PubMed ID: 12861818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
    Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The knowledge and considerations of the physicians regarding the inhaler devices in asthma and COPD: the INTEDA-1 study.
    Calışkaner AZ; Öztürk C; Ceylan E; Pekcan S; Yılmaz Ö; Öztürk S; Can C; Şener O; Yılmaz Turay Ü; Koç N; Ersoy R
    Tuberk Toraks; 2013; 61(3):183-92. PubMed ID: 24298959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintaining Control of Chronic Obstructive Airway Disease: Adherence to Inhaled Therapy and Risks and Benefits of Switching Devices.
    Melani AS; Paleari D
    COPD; 2016; 13(2):241-50. PubMed ID: 26407924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants and Differences in Satisfaction with the Inhaler Among Patients with Asthma or COPD.
    Plaza V; Giner J; Curto E; Alonso-Ortiz MB; Orue MI; Vega JM; Cosío BG;
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):645-653. PubMed ID: 31586668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma.
    Capstick TG; Clifton IJ
    Expert Rev Respir Med; 2012 Feb; 6(1):91-101; quiz 102-3. PubMed ID: 22283582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment.
    Hawken N; Torvinen S; Neine ME; Amri I; Toumi M; Aballéa S; Plich A; Roche N
    BMC Pulm Med; 2017 Jul; 17(1):99. PubMed ID: 28683805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Real-life use of inhaler devices for chronic obstructive pulmonary disease in primary care].
    Girodet PO; Raherison C; Abouelfath A; Lignot S; Depont F; Moore N; Molimard M
    Therapie; 2003; 58(6):499-504. PubMed ID: 15058493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.